Hepatobiliary Pathologies and Liver Neoplasms

Benign Hepatic Tumours

Not all liver growths are cancerous. Benign tumours are non-malignant growths that, while often asymptomatic, require careful identification to differentiate them from more dangerous lesions.

• Hepatic Cell Adenoma: These tumours consist of cells that closely resemble normal hepatocytes but lack the organized lobular structure of healthy liver tissue. There is a strong association between these adenomas and the use of estrogen-containing oral contraceptives, particularly in young females. While many are stable, approximately 5% can undergo malignant transformation, and larger tumours (> 5 cm) often require surgical resection.
• Hepatic Hemangioma: This is the most common benign liver tumour, with an estimated prevalence of 2–7% in the population. Hemangiomas are composed of vascular tissue embedded within a collagen stroma. They are typically asymptomatic and discovered incidentally.
• Bile Duct Adenoma: These are small, white nodules that arise from the epithelium of the intrahepatic bile ducts. They account for about 1% of primary liver tumours and are often asymptomatic, though they can be difficult to distinguish from metastatic adenocarcinomas during imaging.

Primary Liver Malignancies

Primary malignancies arise from the specific cell types that constitute the liver or its biliary system. They are categorized based on their cell of origin:

Hepatocellular Carcinoma (HCC)

HCC is the most prevalent primary liver malignancy, accounting for approximately 90% of all cases. It arises from the hepatocytes themselves. Key risk factors include the consumption of aflatoxins, chronic viral hepatitis, and hereditary hemochromatosis. HCC is characterized by rapid growth and a tendency for early metastasis via the hepatic and portal veins. Clinical signs can include vague abdominal symptoms (anorexia, nausea), and in advanced stages, jaundice, ascites, and portal hypertension.

Cholangiocarcinoma

Arising from the biliary epithelium, cholangiocarcinoma represents about 10% of primary liver cancers. Its etiology is often linked to cholangitis (bile duct inflammation) or liver fluke infections. Because these tumours often cause biliary obstruction, patients frequently present with symptoms such as jaundice, pruritus (itching), light-colored stools, and dark urine. The prognosis is generally poor, with a 5-year survival rate of less than 10%.

Angiosarcoma

This is a rare malignancy, accounting for only about 2% of primary liver cancers. It originates from the vascular endothelial cells and forms numerous hemorrhagic and necrotic nodules. Risk factors include exposure to certain chemicals (such as arsenic or vinyl chloride) and the use of anabolic steroids.

Secondary (Metastatic) Carcinoma

While primary liver cancers are significant, secondary (metastatic) carcinoma is actually much more common. The liver is a frequent site for metastases from other organs (such as the colon or pancreas) due to several physiological factors:

1. It receives a massive volume of blood.
2. The blood supply is exceptionally rich in nutrients.
3. It possesses an extensive lymphatic drainage system.

Patients with secondary carcinomas often present with marked hepatomegaly (enlarged liver), splenomegaly (enlarged spleen), and rapid cachexia (severe weight loss and muscle wasting). The prognosis for these patients is typically very poor; because the tumours are often widespread, they are frequently non-resectable, and the 5-year survival rate is often less than 5%.

Exam Note: If a question asks which type of liver cancer is most common, distinguish between primary (HCC) and overall (Secondary/Metastatic). Metastatic cancer is the most frequent way cancer presents in the liver.